Kim J and Alger BE |
Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. |
2004 |
Nat. Neurosci. |
pmid:15184902
|
Marsicano G and Chaouloff F |
Moving bliss: a new anandamide transporter. |
2012 |
Nat. Neurosci. |
pmid:22193249
|
Self DW |
Anandamide: a candidate neurotransmitter heads for the big leagues. |
1999 |
Nat. Neurosci. |
pmid:10204533
|
Giuffrida A et al. |
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. |
1999 |
Nat. Neurosci. |
pmid:10204543
|
Kim J and Alger BE |
Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. |
2010 |
Nat. Neurosci. |
pmid:20348918
|
Maccarrone M et al. |
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. |
2008 |
Nat. Neurosci. |
pmid:18204441
|
Di Marzo V |
Anandamide serves two masters in the brain. |
2010 |
Nat. Neurosci. |
pmid:21102567
|
Clapper JR et al. |
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. |
2010 |
Nat. Neurosci. |
pmid:20852626
|
Di Marzo V |
Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight. |
2011 |
Nat. Neurosci. |
pmid:21187849
|
Chávez AE et al. |
TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. |
2010 |
Nat. Neurosci. |
pmid:21076423
|
Fu J et al. |
A catalytically silent FAAH-1 variant drives anandamide transport in neurons. |
2012 |
Nat. Neurosci. |
pmid:22101642
|
Gerdeman GL et al. |
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. |
2002 |
Nat. Neurosci. |
pmid:11976704
|
Balas L et al. |
Synthesis of a photoactivatable probe of the anandamide re-uptake. |
2005 |
Nat. Prod. Res. |
pmid:15938150
|
Mechoulam R et al. |
Anandamide may mediate sleep induction. |
1997 |
Nature |
pmid:9288961
|
Hohmann AG et al. |
An endocannabinoid mechanism for stress-induced analgesia. |
2005 |
Nature |
pmid:15973410
|
Iversen L |
Pharmacology. Endogenous cannabinoids. |
1994 |
Nature |
pmid:7990950
|
Calignano A et al. |
Control of pain initiation by endogenous cannabinoids. |
1998 |
Nature |
pmid:9685157
|
Di Marzo V et al. |
Formation and inactivation of endogenous cannabinoid anandamide in central neurons. |
1994 |
Nature |
pmid:7990962
|
Zygmunt PM et al. |
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. |
1999 |
Nature |
pmid:10440374
|
Iversen LL |
Pharmacology. Medical uses of marijuana? |
1993 |
Nature |
pmid:8395659
|
Munro S et al. |
Molecular characterization of a peripheral receptor for cannabinoids. |
1993 |
Nature |
pmid:7689702
|
Premkumar LS and Ahern GP |
Induction of vanilloid receptor channel activity by protein kinase C. |
2000 Dec 21-28 |
Nature |
pmid:11140687
|
di Tomaso E et al. |
Brain cannabinoids in chocolate. |
1996 |
Nature |
pmid:8751435
|
RodrÃguez de Fonseca F et al. |
An anorexic lipid mediator regulated by feeding. |
2001 |
Nature |
pmid:11700558
|
Davis JB et al. |
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. |
2000 |
Nature |
pmid:10821274
|
Venance L et al. |
Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. |
1995 |
Nature |
pmid:7637807
|
Watanabe H et al. |
Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. |
2003 |
Nature |
pmid:12879072
|
Cravatt BF et al. |
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. |
1996 |
Nature |
pmid:8900284
|
Calignano A et al. |
Bidirectional control of airway responsiveness by endogenous cannabinoids. |
2000 |
Nature |
pmid:11081515
|
Mechoulam R and Fride E |
Physiology. A hunger for cannabinoids. |
2001 |
Nature |
pmid:11298428
|
Mechoulam R |
Todd's achievement. |
1997 |
Nature |
pmid:9126725
|
Wagner JA et al. |
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. |
1997 |
Nature |
pmid:9394002
|
Stella N et al. |
A second endogenous cannabinoid that modulates long-term potentiation. |
1997 |
Nature |
pmid:9285589
|
Barthó L et al. |
Nitric oxide is involved in the relaxant effect of capsaicin in the human sigmoid colon circular muscle. |
2002 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:12382081
|
Holt S and Fowler CJ |
Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra- but not intracellular pH. |
2003 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:12644895
|
Schulte K et al. |
Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor. |
2012 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:22215206
|
del Carmen GarcÃa M et al. |
Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats. |
2003 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:14504685
|
Baranowska-Kuczko M et al. |
Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries. |
2014 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:24682422
|
Molderings GJ et al. |
Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship. |
1999 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10494885
|
Akinshola BE et al. |
Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP. |
1999 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10543424
|
Fisar Z |
Inhibition of monoamine oxidase activity by cannabinoids. |
2010 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:20401651
|
Malinowska B et al. |
Involvement of central beta2-adrenergic, NMDA and thromboxane A2 receptors in the pressor effect of anandamide in rats. |
2010 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:20198363
|
Terranova JP et al. |
Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. |
1995 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:8751088
|
Zygmunt PM et al. |
Differential actions of anandamide, potassium ions and endothelium-derived hyperpolarizing factor in guinea-pig basilar artery. |
2000 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10832608
|
Ilayan E et al. |
Do cannabinoids exhibit a tyramine-like effect? |
2013 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:23900610
|
Avelino A and Cruz F |
TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications. |
2006 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:16721555
|
Jergas B et al. |
O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus. |
2014 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:24853577
|
Steffens M et al. |
Quantitative measurement of depolarization-induced anandamide release in human and rat neocortex. |
2003 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:14566450
|
Kracke GR et al. |
The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes. |
2007 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:17960365
|
Crozier Willi G et al. |
Lipids in neural function: modulation of behavior by oral administration of endocannabinoids found in foods. |
2001 |
Nestle Nutr Workshop Ser Clin Perform Programme |
pmid:11510437
|